Rom S. Leidner, Prakash Ambady, Emily Lin, Neda Jooya, Amber Ruiz, Christopher J. Darus, Cassandra Niemi, Binbin Zheng-Lin, Tara Foote, Ashley Drokin, Alex Tran, Grayson DuRaine, Douglas A. Hanes, William L. Redmond, Bernard A. Fox, Alan Korman, Matthew H. Taylor. "A first-in-human phase I clinical trial evaluating the safety, tolerability, and preliminary efficacy of the novel fas ligand (FasL) inhibitor M3T01 in adults with advanced solid tumors.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps2670